1.78
price up icon0.00%   0.00
after-market Dopo l'orario di chiusura: 1.82 0.04 +2.25%
loading

Milestone Pharmaceuticals Inc Azioni (MIST) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Research and Development
26.30%
3.669
4.978 3.94 3.963 2.815
Operating Income/Loss
38.94%
-12.53
-20.52 -12.35 -9.616 -9.662
Income/Loss From Continuing Operations Before Tax
37.55%
-12.97
-20.76 -12.36 -9.439 -9.363
Income/Loss From Continuing Operations After Tax
37.55%
-12.97
-20.76 -12.36 -9.439 -9.363
Net Income/Loss
37.55%
-12.97
-20.76 -12.36 -9.439 -9.363
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Earnings Per Share
35.48%
-0.20
-0.31 -0.19 -0.14 -0.14
Diluted Earnings Per Share
35.48%
-0.20
-0.31 -0.19 -0.14 -0.14
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$85.44
price down icon 1.75%
$27.38
price up icon 1.11%
$23.80
price up icon 1.19%
$103.50
price up icon 3.07%
$142.53
price down icon 0.68%
biotechnology ONC
$318.73
price down icon 5.21%
Capitalizzazione:     |  Volume (24 ore):